Logo Logo
Switch Language to German

Hehlmann, R., Lauseker, Michael, Jung-Munkwitz, S., Leitner, A., Müller, M. C., Pletsch, N., Proetel, U., Haferlach, C., Schlegelberger, B., Balleisen, L., Hänel, M., Pfirrmann, Markus, Krause, S. W., Nerl, C., Pralle, H., Gratwohl, A., Hossfeld, D. K., Hasford, Joerg, Hochhaus, A. and Saußele, Susanne (2011): Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-alpha in newly diagnosed chronic myeloid leukemia. In: Journal of Clinical Oncology, Vol. 29, No. 12: pp. 1634-1642

Full text not available from 'Open Access LMU'.

Actions (login required)

View Item View Item